Publications by authors named "Deborah Dillon"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

164

Total Likes

355

Extended Reach

597,227

Social Features

111
C
Contrastive learning enhances fairness in pathology artificial intelligence systems.
Shih-Yen Lin, Pei-Chen Tsai, Fang-Yi Su, Chun-Yen Chen, Fuchen Li, Deborah Dillon

Cell Rep Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapies.
Tam Binh V Bui, Denise M Wolf, Michael C Bruck, Kaitlin Moore, Jessica Lien, Deborah Dillon

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic Characterization of Inflammatory Breast Cancer.
Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa E Hughes, Yvonne Li, Deborah Dillon

Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform.
Yuqing Zhang, Zehua Li, Jessica Ritter, Elliott J Brea, Navin R Mahadevan, Deborah A Dillon

Cell Rep Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do transition to practice hour requirements make a difference in adverse action and medical malpractice payment reports: An analysis from the National Practitioner Data Bank.
Deborah Dillon

J Am Assoc Nurse Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation.
Nam Woo Cho, Sophia M Guldberg, Barzin Y Nabet, Jie Zeng Yu, Eun Ji Kim, Deborah A Dillon

Cancer Immunol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival.
Alyssa M Pereslete, Melissa E Hughes, Alyssa R Martin, Janet Files, Kyleen Nguyen, Deborah Dillon

Neuro Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations.
Marc J Williams, Michael U J Oliphant, Vinci Au, Cathy Liu, Caroline Baril, Deborah A Dillon

Nat Genet· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness.
Kung-Chi Chang, Francesca Silvestri, Michael U J Oliphant, M Angie Martinez-Gakidis, Dennis P Orgill, Deborah D Dillon

NPJ Breast Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pathology foundation model for cancer diagnosis and prognosis prediction.
Xiyue Wang, Junhan Zhao, Eliana Marostica, Wei Yuan, Jietian Jin, Deborah Dillon

Nature· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness.
Joan Brugge, Kung-Chi Chang, Francesca Silvestri, Michael Olipant, M Angie Martinez-Gakidis, Deborah Dillon

Res Sq· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer.
Daniel Xia, Frank Kuo, Melissa Hughes, Neal Lindeman, Danielle Manning, Deborah A Dillon

Am J Clin Pathol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luminal breast epithelial cells from wildtype and mutation carriers harbor copy number alterations commonly associated with breast cancer.
Marc J Williams, Michael Uj Oliphant, Vinci Au, Cathy Liu, Caroline Baril, Deborah Dillon

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic characterization of inflammatory breast cancer.
Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa Hughes, Yvonne Li, Deborah Dillon

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer.
Jennifer L Guerriero, Jia-Ren Lin, Ricardo G Pastorello, Ziming Du, Yu-An Chen, Deborah A Dillon

NPJ Breast Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.
Jun Nishida, Simona Cristea, Sudheshna Bodapati, Julieann Puleo, Gali Bai, Deborah Dillon

Proc Natl Acad Sci U S A· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Paolo Tarantino, Hersh Gupta, Melissa E Hughes, Janet Files, Sarah Strauss, Deborah Dillon

Nat Commun· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Bojana Jovanović, Daniel Temko, Laura E Stevens, Marco Seehawer, Anne Fassl, Deborah Dillon

Cell Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Paolo Tarantino, Hersh Gupta, Melissa E Hughes, Janet Files, Sarah Strauss, Deborah Dillon

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis in Young Women Treated for Breast Cancer.
Christopher J Gibson, Geoffrey Fell, Tal Sella, Adam S Sperling, Craig Snow, Deborah Dillon

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progression.
Hai P Nguyen, Rory Sheng, Elizabeth Murray, Yusuke Ito, Michael Bruck, Deborah A Dillon

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic abnormalities and survival among patients with non-metastatic breast cancer.
Alexa S Zimbalist, Bette J Caan, Wendy Y Chen, Elizabeth A Mittendorf, Deborah A R Dillon

BMC Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escape from breast tumor dormancy: The convergence of obesity and menopause.
Roopali Roy, Jiang Yang, Takaya Shimura, Lauren Merritt, Justine Alluin, Deborah Dillon

Proc Natl Acad Sci U S A· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit.
Romualdo Barroso-Sousa, Juliet Forman, Katharine Collier, Zachary T Weber, Tejas R Jammihal, Deborah A Dillon

JCO Precis Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis